Trousseaus Syndrome: Cancer-Associated Thrombosis
Jpn J Clin Oncol 46:204-207, Ikushima, S.,et al, 2016
Differential Diagnosis
Thoracic Key, Southerland,A.W.,et al, 2016
Clinical Interpretation of High-Resolution Vessel Wall MRI of Intracranial Arterial Diseases
Br J Radiol 89:20160496, Lehman,V.T.,et al, 2016
Antiplatelet Treatment Compared with Anticoagulation Treatment for Cervical Artery Dissection (CADISS): A Randomized Trial
Lancet Neurol 14:361-367, the CADISS Trial investigators, 2015
DWI Lesion Patterns in Cancer-Related Stroke-Specifying the Phenotype
Cerebrovasc Dis Extra 5:139-145, Schwarzbach, C.J.,et al, 2015
Reversible Cerebral Vasoconstriction Syndrome, Part 2: Diagnostic Work-Up, Imaging Evaluation, and Differential Diagnosis
AJNR 36:1580-1588, Miller, T.R.,et al, 2015
Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis
Stroke 46:3288-3301, Abbott, A.L.,et al, 2015
Recurrent Stroke in Childhood Cancer Survivors
Neurol 85:1056-1064, Fullerton, H.J.,et al, 2015
Are the Current Risks of Asymptomatic Carotid Stenosis Exaggerated?
JAMA Neurol 72:1233-1234, Chaturvedi, S. & Sacco, R.L., 2015
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
NEJM 373:2413-2424,2471, Siegal, D.M.,et al, 2015
Multimodal Diagnostic Imaging for Hyperacute Stroke
AJNR 36:2206-2213, Vo, K.D.,et al, 2015
Endovascular Treatment for Acute Ischemic Stroke in the Setting of Anticoagulation
Stroke 46:3536-3539, Rebello, L.C.,et al, 2015
Endovascular Therapy is Effective and Safe for Patients with Severe Ischemic Stroke
Stroke 46:3416-3422, Broderick, J.P.,et al, 2015
Foreign Body Emboli Following Cerebrovascular Interventions: Clinical, Radiographic, and Histopathologic Features
AJNR 36:2121-2126, Shapiro, M.,et al, 2015
FDA Approves Praxbind, the First Reversal Agent for the Anticoagulant Pradaxa
JAMA 314:2227, , 2015
Endovascular vs Medical Management of Acute Ischemic Stroke
Neurol 85:1980-1990, Chen, C.J.,et al, 2015
Stroke and Recurrent Haemorrhage Associated with Antithrombotic Treatment after Gastrointestinal Bleeding in Patients with Atrial Fibrillation: Nationwide Cohort Study
BMJ 351:h5876, h6104, Staerk, L.,et al, 2015
Moyamoya Disease Presenting with Subarachnoid Hemorrhage: Clinical Features and Neuroimaging of a Case Series
Brit J Neurosurg 29:804-810, Wan, M.,et al, 2015
Central Retinal Vein Occlusion with Bilateral Stenosis of the Internal Carotid Arteries
Lancet 385:914, Baroon, R. & Carvounis, P.E., 2015
Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection
NEJM 372:1009-1018, Campbell, B.C.V.,et al, 2015
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
NEJM 372:1019-1030, Goyal, M.,et al, 2015
Efficacy of Antiplatelet Therapy in Secondary Prevention Following Lacunar Stroke
Stroke 46:1014-1023, Kwok, C.S.,et al, 2015
Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation
Stroke 46:1120-1122, Tung, J.M.,et al, 2015
Significant Period Between Presentation and Diagnosis in Basilar Artery Occlusion
Stroke 46:e79-e81, Organek, N.,et al, 2015
Effect of a Balloon-Expandable Intracranial Stent vs Medical Therapy on Risk of Stroke in Patients with Symptomatic Intracranial Stenosis
JAMA 313:1240-1248, Zaidat, O.O.,et al, 2015
Recurrence of Reversible Cerebral Vasoconstriction Syndrome
Neurol 84:1552-1558, Chen, S.P.,et al, 2015
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
NEJM 372:DOI:10.1056/NEJMoa1415061, DOI:10.1056 NEJM e1503217, Saver, J.L.,et al, 2015
Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
NEJM 372:DOI:10.1056 NEJMoa1503780, DOI:1056NEJM e1503217, Jovin, T.G.,et al, 2015
Mechanical Thrombectomy in Cerebral Venous Thrombosis
Stroke 46:1263-1268, Siddiqui, F.M.,et al, 2015
Prehospital Reversal of Warfarin-Related Coagulopathy in Intracerebral Hemorrhage in a Mobile Stroke Treatment Unit
Stroke 46:e118-e120, Gomes, J.A.,et al, 2015
Hyperbaric Oxygen Therapy for Acute Ischemic Stroke
Stroke 46:e109-e110, Bennett, M.H.,et al, 2015
Risk of Gastrointestinal Bleeding Associated with Oral Anticoagulants: Population Based Retrospective Cohort Study
BMJ 350:h1585, h1679, Chang, H.Y.,et al, 2015
Comparative Risk of Gastrointestinal Bleeding with Dabigatran, Rivaroxaban, and Warfarin: Population Based Cohort Study
BMJ 350:h1857, h1979, Abraham, N.S.,et al, 2015
Stroke Prevention in Atrial Fibrillation
JAMA 313:1950-1962, Lip, G.Y.H. & Lane, D.A., 2015
Investigating Intracerebral Haemorrhage
BMJ 350:h2484, Wilson, D.,et al, 2015
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
NEJM 372:2285-2295,2347, Saver, J.L.,et al, 2015
Thrombectomy within 8 hours after Symptom Onset in Ischemic Stroke
NEJM 372:2296-2306,2347, Jovin, T.G.,et al, 2015
A 66-year-old man with Recurrent Multi-Territory Infarcts
Neurol 84:e195-e201, Kouzmitcheva, E.,et al, 2015
Care and Outcomes of Patients with In-Hospital Stroke
JAMA Neurol 72:749-755,746, Saltman, A.P.,et al, 2015
Recovery from Locked-In Syndrome
JAMA Neurol 72:832-833, Hocker, S. & Wijdicks, E.F.M., 2015
Peri-Procedural Management of Patients Taking Oral Anticoagulants
BMJ 351:h2391, Daniels, P.R., 2015
Screening with MRI for Accurate and Rapid Stroke Treatment
Neurol 84:2438-2444, 2394, Shah, S.,et al, 2015
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
Stroke 46:2032-2060, Hemphill, J.C.,et al, 2015
Intracranial Dural Arteriovenous Fistulae
Stroke 46:2017-2025, Miller, T.R. & Gandhi, D., 2015
Parkinsons Disease Beyond 20 Years
JNNP 86:849-855, Cilia, R.,et al, 2015
Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Current Status, Special Situations, and Unmet Needs
Lancet 386:303-310, Verheugt, F.W.A. & Granger, C.B., 2015
Futile Interhospital Transfer for Endovascular Treatment in Acute Ischemic Stroke
Stroke 46:2156-2161, Fuentes, B.,et al, 2015
Effect of Clopidogrel with Aspirin on Functional Outcome in TIA or Minor Stroke
Neurol 85:573-579,562, Wang, X.,et al, 2015
Reversible Cerebral Vasoconstriction Syndrome, Part 1: Epidemiology, Pathogenesis, and Clinical Course
AJNR 36:1392-1399, Miller, T.R.,et al, 2015
Idarucizumab for Dabigatran Reversal
NEJM 373:511-520, Pollack, C.V.,et al, 2015